Back
Verrica Pharmaceuticals Vs. AAR Industry Stock Comparison
Sell
17
VRCA
Verrica Pharmaceuticals
Last Price:
$0.44
Seasonality Move:
-7.87%
Sell
11
AIR
AAR
Last Price:
$57.64
Seasonality Move:
1.71%
Sell
17
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.42. The Score for VRCA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight selling pressure.
AIR Stock Price Chart
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 29.39 | Sell |
Chaikin Money Flow: | 15247 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.5 - 0.66) | Sell |
Bollinger Bands (100): | (0.55 - 0.95) | Sell |
AIR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.52 | Sell |
Relative Strength Index (14 RSI): | 24.65 | Sell |
Chaikin Money Flow: | 112112 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.16 - 69) | Sell |
Bollinger Bands (100): | (62.23 - 69.47) | Sell |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.47 | Sell |
20-day SMA: | 0.56 | Sell |
50-day SMA: | 0.64 | Sell |
200-day SMA: | 2.52 | Sell |
8-day EMA: | 0.47 | Sell |
20-day EMA: | 0.54 | Sell |
50-day EMA: | 0.65 | Sell |
200-day EMA: | 2.11 | Sell |
AIR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.26 | Sell |
20-day SMA: | 65.34 | Sell |
50-day SMA: | 66.48 | Sell |
200-day SMA: | 65.8 | Sell |
8-day EMA: | 61.92 | Sell |
20-day EMA: | 64.47 | Sell |
50-day EMA: | 65.43 | Sell |
200-day EMA: | 65.33 | Sell |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.16 per share.
AAR Earnings Growth & AIR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.04 per share, an increase this year of $0.46 per share, and an increase next year of $0.73 per share.
Verrica Pharmaceuticals Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AAR Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |